Comment
doi: 10.1016/S0140-6736(16)31038-8.
STAMPEDE trial and patients with non-metastatic prostate cancer
Affiliations
- PMID: 27479564
- DOI: 10.1016/S0140-6736(16)31038-8
Item in Clipboard
Comment
STAMPEDE trial and patients with non-metastatic prostate cancer
Lancet.
.
No abstract available
Comment in
-
STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.Lancet. 2016 Jul 16;388(10041):235-6. doi: 10.1016/S0140-6736(16)31041-8. Lancet. 2016. PMID: 27479566 No abstract available.
Comment on
-
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.Lancet. 2016 Mar 19;387(10024):1163-77. doi: 10.1016/S0140-6736(15)01037-5. Epub 2015 Dec 21. Lancet. 2016. PMID: 26719232 Free PMC article. Clinical Trial.
Similar articles
-
STAMPEDE trial and patients with non-metastatic prostate cancer - Authors' reply.Lancet. 2016 Jul 16;388(10041):235-6. doi: 10.1016/S0140-6736(16)31041-8. Lancet. 2016. PMID: 27479566 No abstract available.
-
Defining new standards of care for men with prostate cancer.Lancet. 2016 Mar 19;387(10024):1135-7. doi: 10.1016/S0140-6736(15)01235-0. Lancet. 2016. PMID: 27025318 No abstract available.
-
Prostate cancer: Changing standard of care in hormone-sensitive disease.Nat Rev Urol. 2016 Feb;13(2):61. doi: 10.1038/nrurol.2016.4. Epub 2016 Jan 20. Nat Rev Urol. 2016. PMID: 26787390 No abstract available.
-
[Optimal treatment for elderly high-risk prostate cancer patients].Gan To Kagaku Ryoho. 2007 Mar;34(3):387-92. Gan To Kagaku Ryoho. 2007. PMID: 17353629 Review. Japanese.
-
Chemotherapy for metastatic castrate-sensitive prostate cancer.Prostate Cancer Prostatic Dis. 2016 Jun;19(2):139-44. doi: 10.1038/pcan.2016.10. Epub 2016 Mar 15. Prostate Cancer Prostatic Dis. 2016. PMID: 26976365 Review.
Cited by
-
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression.Nat Commun. 2021 Dec 2;12(1):7033. doi: 10.1038/s41467-021-26840-5. Nat Commun. 2021. PMID: 34857732 Free PMC article.
-
A game changing LATITUDE: Role of abiraterone plus prednisone in metastatic hormonesensitive prostate cancer. [corrected].Indian J Urol. 2017 Oct-Dec;33(4):333-334. doi: 10.4103/iju.IJU_250_17. Indian J Urol. 2017. PMID: 29021663 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
